Non-hereditary degenerative ataxia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:247239
Who is this for?
Show terms as
5Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Non-hereditary degenerative ataxia (also referred to as sporadic degenerative ataxia or idiopathic degenerative ataxia) is a group of progressive neurological conditions characterized by cerebellar degeneration that occurs without a clear genetic or hereditary cause. These conditions primarily affect the cerebellum and its connections, leading to progressive difficulties with coordination, balance, and gait. Unlike hereditary ataxias, non-hereditary degenerative ataxias arise sporadically, meaning they occur in individuals without a family history of ataxia and without an identifiable genetic mutation. The key clinical features include progressive gait ataxia (unsteady walking), limb incoordination, dysarthria (slurred or poorly articulated speech), oculomotor abnormalities (such as nystagmus), and impaired balance. Depending on the specific subtype, additional neurological features may be present, including autonomic dysfunction, parkinsonism, or pyramidal signs. The most well-recognized entity within this group is sporadic adult-onset ataxia of unknown etiology, though some cases may evolve into multiple system atrophy of the cerebellar type (MSA-C), which involves additional autonomic and motor system dysfunction. Diagnosis is typically one of exclusion, requiring thorough investigation to rule out hereditary ataxias (through genetic testing), acquired causes (such as alcohol toxicity, vitamin deficiencies, autoimmune conditions, or paraneoplastic syndromes), and structural lesions. Brain MRI typically reveals cerebellar atrophy. Currently, there is no curative treatment for non-hereditary degenerative ataxia. Management is supportive and symptomatic, including physical therapy and occupational therapy to maintain mobility and function, speech therapy for dysarthria, and pharmacological interventions for specific symptoms. Regular monitoring is important to detect any evolution toward multiple system atrophy or other defined conditions.

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Non-hereditary degenerative ataxia.

View clinical trials →

No actively recruiting trials found for Non-hereditary degenerative ataxia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Non-hereditary degenerative ataxia community →

Specialists

5 foundView all specialists →
MP
Marie Claire VINCENT, PhD-PharmaD
Specialist
PI on 2 active trials
LS
Laurent Servais
Specialist
PI on 1 active trial28 Non-hereditary degenerative ataxia publications
TP
Tao Xie, MD PhD
Specialist
PI on 1 active trial
AM
Ahmad Yasa MD
Specialist
PI on 1 active trial1 Non-hereditary degenerative ataxia publication
YM
Yoga Yudhistira MD
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Non-hereditary degenerative ataxia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Non-hereditary degenerative ataxiaForum →

No community posts yet. Be the first to share your experience with Non-hereditary degenerative ataxia.

Start the conversation →

Latest news about Non-hereditary degenerative ataxia

No recent news articles for Non-hereditary degenerative ataxia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Non-hereditary degenerative ataxia

What is Non-hereditary degenerative ataxia?

Non-hereditary degenerative ataxia (also referred to as sporadic degenerative ataxia or idiopathic degenerative ataxia) is a group of progressive neurological conditions characterized by cerebellar degeneration that occurs without a clear genetic or hereditary cause. These conditions primarily affect the cerebellum and its connections, leading to progressive difficulties with coordination, balance, and gait. Unlike hereditary ataxias, non-hereditary degenerative ataxias arise sporadically, meaning they occur in individuals without a family history of ataxia and without an identifiable genetic

How is Non-hereditary degenerative ataxia inherited?

Non-hereditary degenerative ataxia follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Non-hereditary degenerative ataxia typically begin?

Typical onset of Non-hereditary degenerative ataxia is adult. Age of onset can vary across affected individuals.

Which specialists treat Non-hereditary degenerative ataxia?

5 specialists and care centers treating Non-hereditary degenerative ataxia are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.